Esomeprazole: a Safe Alternative to Lansoprazole Allergy?

Esomeprazole: a Safe Alternative to Lansoprazole Allergy?

LETTER TO THE EDITOR

Bibliographic Details
Main Authors:	Muammer Kara, Alpaslan Tanoglu, Ali Kutlu, Ozgur Sirkeci, Murat Kekilli
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2014-08-01
Series:	Iranian Journal of Allergy, Asthma and Immunology
Subjects:	Allergic reactions Esomeprazole Lansoprazole allergy Proton pump inhibitors
Online Access:	https://ijaai.tums.ac.ir/index.php/ijaai/article/view/442

Similar Items

Comparison of the Effect of Omeprazole, Pantoprazole, Esomeprazole, and Lansoprazole on the Reduction of Symptoms in Patients with Gastroesophageal Reflux Disease
by: Nima Arezoomandi, et al.
Published: (2019-02-01)

Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
by: Hung KT, et al.
Published: (2021-03-01)

Comparative analysis of the effect of PO administered acid suppressants on gastric pH in healthy cats
by: Phillip Ryan, et al.
Published: (2020-09-01)

EVALUATION OF PSORIASIS TREATMENT WITH ESOMEPRAZOLE - A PILOT STUDY
by: Mauro BAFUTTO, et al.

Lansoprazole as an uncommon cause of anaphylaxis: What to give next?
by: Attila Aydın, et al.
Published: (2019-09-01)

Pharmacokinetics of esomeprazole following intravenous and oral administration in healthy dogs
by: Cook EK, et al.
Published: (2016-08-01)

Pharmacokinetic Study and Incurred Sample Stability of Esomeprazole in Dried Blood Spot Sample Using High Performance Liquid Chromatography-Photodiode Array
by: Yahdiana Harahap, et al.
Published: (2020-07-01)

Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway
by: Afshin Ebrahimpour, et al.
Published: (2021-05-01)

Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors
by: Spugnini Enrico P, et al.
Published: (2011-12-01)

Clinical and pharmacoeconomic profile of esomeprazole in acid-related diseases
by: Orietta Zaniolo
Published: (2006-09-01)

The Effect of Esomeprazole 40 mg Single Therapy in Patients with Non-Erosive Reflux Disease Who Are Resistant to Standard-Dose Proton Pump Inhibitor Therapy: An Open-Label Multicenter Study
by: Jae Kyu Sung, et al.
Published: (2016-12-01)

Efficacy of Seven-day High-dose Esomeprazole-based Triple Therapy versus Seven-day Standard Dose Non-esomeprazole-based Triple Therapy as the First-line Treatment of Patients with Helicobacter pylori Infection
by: Young Dal Lee, et al.
Published: (2020-09-01)

Clinical and endoscopic evaluantion of gastroesophageal reflux disease in patients successfully treated with esomeprazole Avaliação clínica e endoscópica da doença do refluxo gastroesofágico em pacientes tratados com esomeprazol
by: Edson Pedro da Silva, et al.
Published: (2003-12-01)

Mandibular Osteonecrosis Associated with Antacid Therapy (Esomeprazole)
by: Simone Marconcini, et al.
Published: (2019-10-01)

Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials
by: David A. Peura, et al.
Published: (2018-05-01)

Lansoprazole in treatment of duodenal ulcer desease
by: V. V. Skvortsov, et al.
Published: (2019-05-01)

In vitro comparative quality evaluation of different brands of esomeprazole tablets available in selected community pharmacies in Dhaka, Bangladesh
by: Oby dulla, et al.
Published: (2018-03-01)

Practical considerations in the management of proton-pump inhibitors
by: Lara Aguilera-Castro, et al.

Therapeutic Response to 20 mg of Esomeprazole Twice Daily in Patients with Gastroesophageal Reflux Disease-related Non-cardiac Chest Pain: An Open-Label Randomized Pilot Study
by: Jae Kyun Choi, et al.
Published: (2020-06-01)

A case of probable esomeprazole-induced transient liver injury in a pregnant woman with hyperemesis
by: Thomas B, et al.
Published: (2016-12-01)

Effects of caffeine, tea polyphenol and daidzein on the pharmacokinetics of lansoprazole and its metabolites in rats
by: Tao Wu, et al.
Published: (2015-12-01)

Esomeprazole Increases Airway Surface Liquid pH in Primary Cystic Fibrosis Epithelial Cells
by: Livia Delpiano, et al.
Published: (2018-12-01)

Determinação de lansoprazol em cápsulas utilizando metodologia baseada em imagens digitais
by: Lima, Arlesson Freire de
Published: (2015)

Lansoprazole for recurrent abdominal pain in adolescents
by: Ade Saifan Surya, et al.
Published: (2011-08-01)

The effect of lansoprazole administration during pregnancy on the placenta
by: Ali Louei Monfared, et al.
Published: (2017-03-01)

Comparative study of Lansoprazole and Rabeprazole on ulcer healing property on albino rats
by: Amit Kumar Jha*
Published: (2012-01-01)

Possibilities for prescribing lansoprazole in the outpatient practice
by: I. G. Pakhomova, et al.
Published: (2019-08-01)

Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey
by: Mustafa Iscan, et al.
Published: (2011-09-01)

Ratio - First Order Derivative - Zero Crossing UV-Visible Spectrophotometric Method for Analysis of Amoxicillin, Levofloxacin and Lansoprazole Mixture
by: Mustafa Gülfen, et al.
Published: (2020-06-01)

Effect of lansoprazole on quality of life in adolescents with recurrent abdominal pain
by: Sri Yanti Harahap, et al.
Published: (2013-04-01)

Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori
by: Yoshimasa Saito, et al.
Published: (2019-01-01)

The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male
by: Kim D, et al.
Published: (2019-09-01)

Lansoprazole and its Metabolites in the Treatment of TNBC and the Contribution of ABCG2 to CC-115 Resistance
by: Beebe, Jennifer Diane
Published: (2019)

Indications, diagnostic tests and Helicobacter pylori eradication therapy: Recommendations by the 2nd Spanish Consensus Conference Indicaciones, métodos diagnósticos y tratamiento erradicador de Helicobacter pylori: Recomendaciones de la II Conferencia Española de Consenso
by: J. Monés, et al.
Published: (2005-05-01)

Comparative study of Lansoprazole and Rabeprazole on ulcer healing property on albino rats
by: Amit Kumar Jha, et al.
Published: (2012-11-01)

Effect of Helicobacter pylori infection and acid blockade by lansoprazole on clarithromycin bioavailability
by: R.A.M. Ortiz, et al.
Published: (2007-03-01)

A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial
by: Tai WC, et al.
Published: (2019-09-01)

Pharmacokinetics and Anti-Gastric Ulceration Activity of Oral Administration of Aceclofenac and Esomeprazole in Rats
by: Tae Hwan Kim, et al.
Published: (2018-09-01)

Influence of the Impregnation Technique on the Release of Esomeprazole from Various Bioaerogels
by: Milica Pantić, et al.
Published: (2021-06-01)

Development of a simple UV-spectrophotometric method for the determination of lansoprazole and study of its degradation profile
by: Zenita Devi Okram, et al.
Published: (2012-01-01)